Join Our Movement to Restore Your Right to Pain Relief! #EndPainPatientAbuse
Pain Warriors Unite - (202) 792-5600
April 24, 2019
Andrew Kolodny, MD, told an Rx Drug Abuse & Heroin Summit audience that it is time to close the cash pipeline that helped feed the opioid epidemic.
April 23, 2019
The federally supported Healing Communities Study could dramatically reshape the effort to address the harms caused by the opioid crisis, attendees of the Rx Drug Abuse & Heroin Summit heard on Tuesday.
April 23, 2019
Ed Thompson, president of Pharmaceutical Manufacturing Research Services, explained to attendees at the Rx Drug Abuse & Heroin Summit why he wants the FDA to start requiring substantial scientific evidence of efficacy for the intended use of new…
April 16, 2019
President Donald J. Trump and First Lady Melania Trump will address participants of the eighth annual Rx Drug Abuse & Heroin Summit on April 24 in Atlanta.
April 12, 2019
Researchers who developed a tracking system to better understand the evolution of insurance coverage for opioid use disorder will share their findings at the Rx Summit.
FOR IMMEDIATE RELEASE:
Washington, DC (April 16, 2019) — In 2016, the Centers for Disease Control and Prevention (CDC) issued prescribing guidelines to reduce the risks associated with long-term opioid therapy for chronic pain. What followed, however, was widespread misapplication by physicians, as well as insurers, government agencies, pharmacy chains, and health employers, which invoked the guideline as grounds to involuntarily reduce — and in some cases cease — opioid treatment for many chronic pain patients.
AEI Resident Scholar Sally Satel, M.D., in conjunction with other physicians and members of Health Professionals for Patients in Pain (HP3), explained in an open letter to the CDC: “Patients with chronic pain, who are stable and, arguably, benefiting from long-term opioids, face draconian and often rapid involuntary dose reductions.
Often, alternative pain care options are not offered, not covered by insurers, or not accessible. Others are pushed to undergo addiction treatment or invasive procedures (such as spinal injections), regardless of whether clinically appropriate.” Consequences have included intensification of pain, relapse into a disabled state, and even suicide.
Last week, Dr. Satel and her HP3 coauthors were delighted to receive a letter from the CDC in response to their open letter. In his reply, CDC Director Robert R. Redfield assured Dr. Satel and her coauthors — and, by extension, all prescribers, pharmacists, administrators, and regulators — that “the Guideline does not endorse mandated or abrupt dose reduction or discontinuation as these actions can result in patient harm.”
“We are so grateful to the CDC for its essential clarification,” said Dr. Satel. “Now it’s time for the federal, state, and nongovernmental institutions that have invoked the CDC’s authority to push [for] . . . traumatic changes . . . to reverse course.”
The full open letter from HP3 to the CDC is available here.
The full response from the CDC is available here.
Dr. Satel’s Wall Street Journal article on the CDC’s guideline reassessment is available here.
Practical Pain Management:
Fox News' Greg Gutfeld has been reporting about our plight for several months. Watch the most recent segment about the CDC Clarification featured on "The Five"
Click BELOW to watch the segment Featured on "THE FIVE"
This is a three-part series on the nation's struggle to address a crippling opioid crisis, and the unintended victims left in its wake.
By Elizabeth Llorente | Fox News
Dec. 10, 2018 - The national opioid crisis propelled a crackdown on prescription painkillers, causing hundreds of doctors to abruptly reduce or completely cut off their patients’ prescriptions, leaving many among the estimated 20 million Americans who suffer from daily debilitating chronic pain to consider suicide. This is the story of the overlooked victims of America's opioid epidemic.
Dec. 11, 2018 - As federal and state agencies respond to the staggering rate of drug overdose deaths -- primarily involving illegal opioids like heroin and illicit fentanyl -- doctors who maintain they are responsibly prescribing opioids are getting caught up in the crackdown. This is their side of the story to the opioid crisis and how it has impacted -- and for some -- ruined their lives.
Dec. 12, 2018 - The government has addressed the overdose epidemic with an aggressive focus on reducing prescribing practices, which has unintentionally led many doctors to cut down or cut off their patients’ pain medications altogether. This tactic has left many chronic pain sufferers undertreated, with some even contemplating taking their own life. Fox News spoke with numerous doctors, specialists and scholars to find out what the next steps should be to address these unintended consequences.
Fentanyl is now the most commonly used drug involved in drug overdoses, according to a new government report. The latest numbers from the US Centers for Disease Control and Prevention's National Center for Health Statistics say that the rate of drug overdoses involving the synthetic opioid skyrocketed by about 113% each year from 2013 through 2016.
At its 2018 interim meeting in Maryland, the AMA House of Delegates adopted a series of resolutions that recognize the mistreatment of pain patients and call for restraint in implementing the CDC guideline – particularly as it applies to the agency’s maximum recommended dose of 90mg MME (morphine milligram equivalent units).
1. RESOLVED that our AMA affirms that some patients with acute or chronic pain can benefit from taking opioids at greater dosages than recommended by the CDC Guidelines for Prescribing Opioids for chronic pain and that such care may be medically necessary and appropriate.
2. RESOLVED that AMA advocate against the misapplication of the CDC Guidelines for Prescribing Opioids by pharmacists, health insurers, pharmacy benefit managers, legislatures, and governmental and private regulatory bodies in ways that prevent or limit access to opioid analgesia
3. RESOLVED that our AMA advocate that no entity should use MME (morphine milligram equivalents) thresholds as anything more than guidance, and physicians should not be subject to professional discipline, loss of board certification, loss of clinical privileges, criminal prosecution, civil liability, or other penalties or practice limitations solely for prescribing opioids at a quantitative level above the MME thresholds found in the CDC Guidelines for Prescribing Opioids.
Links To Articles:
The sweeping Opioid Legislation package known as HR6 (SUPPORT FOR PATIENTS AND COMMUNITIES ACT) was signed by President Trump on October 24th. Several guests affected by the Opioid Overdose Crisis were in attendance at the White House to witness the signing ceremony.
14th Annual NIH Pain Consortium Symposium
May 30 - 31, 2019
Masur Auditorium and FAES Terrace
Building 10, NIH Campus
The Symposium begins at 8:30 a.m. on Thursday, May 30 and
concludes at 12:00 p.m. on Friday, May 31.
Full Information Here:
Pre-conference registration will stay open
through Thursday, May 23, 2019
Click BELOW to Register